RNLX Renalytix AI

USD 0.86 -0.05 -5.494505
Icon

Renalytix AI (RNLX) Stock Analysis and Price Targets

COMMON STOCK | Health Information Services | NSD
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 0.86

-0.05 (-5.49)%

USD 0.05B

0.38M

N/A

USD 6.00 (+597.67%)

Icon

RNLX

Renalytix AI (USD)
COMMON STOCK | NSD
USD 0.86
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 0.05B

USD 6.00 (+597.67%)

USD 0.86

Renalytix AI (RNLX) Stock Forecast

N/A

Based on the Renalytix AI stock forecast from 0 analysts, the average analyst target price for Renalytix AI is not available over the next 12 months. Renalytix AI’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Renalytix AI is Very Bearish, which is based on 0 positive signals and 8 negative signals. At the last closing, Renalytix AI’s stock price was USD 0.86. Renalytix AI’s stock price has changed by -6.61% over the past week, +3.61% over the past month and -60.37% over the last year.

No recent analyst target price found for Renalytix AI
No recent average analyst rating found for Renalytix AI

Company Overview Renalytix AI

Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-...Read More

https://renalytix.com

1460 Broadway, New York, NY, United States, 10036

0

June

USD

USA

Adjusted Closing Price for Renalytix AI (RNLX)

Loading...

Unadjusted Closing Price for Renalytix AI (RNLX)

Loading...

Share Trading Volume for Renalytix AI Shares

Loading...

Compare Performance of Renalytix AI Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for RNLX

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Renalytix AI (Sector: Health Information Services )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
GEHC
GE HealthCare Technologies Inc.. +0.60 (+0.66%) USD42.33B 30.58 13.92

ETFs Containing RNLX

Symbol Name RNLX's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Renalytix AI (RNLX) Stock

Stock Target Advisor's fundamental analysis for Renalytix AI's stock is Very Bearish.

Unfortunately we do not have enough data on RNLX's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on RNLX's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on RNLX's stock to indicate if its overvalued.

The last closing price of RNLX's stock was USD 0.86.

The most recent market capitalization for RNLX is USD 0.05B.

Unfortunately we do not have enough analyst data on RNLX's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Renalytix AI's stock.

As per our most recent records Renalytix AI has 0 Employees.

Renalytix AI's registered address is 1460 Broadway, New York, NY, United States, 10036. You can get more information about it from Renalytix AI's website at https://renalytix.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...